S&P 500   4,557.28 (+0.15%)
DOW   35,449.75 (+0.33%)
QQQ   389.64 (+0.12%)
AAPL   190.40 (+0.32%)
MSFT   382.10 (+0.92%)
META   336.35 (+0.49%)
GOOGL   136.34 (-0.05%)
AMZN   146.78 (-0.64%)
TSLA   237.31 (+0.52%)
NVDA   477.29 (-1.06%)
NIO   7.16 (-0.42%)
BABA   75.99 (-1.99%)
AMD   121.92 (-0.60%)
T   16.19 (-0.12%)
F   10.32 (-0.19%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.68 (-0.24%)
DIS   94.16 (-1.06%)
AMC   6.65 (-2.21%)
PFE   29.86 (-0.93%)
PYPL   57.10 (+1.26%)
XOM   104.35 (+0.38%)
S&P 500   4,557.28 (+0.15%)
DOW   35,449.75 (+0.33%)
QQQ   389.64 (+0.12%)
AAPL   190.40 (+0.32%)
MSFT   382.10 (+0.92%)
META   336.35 (+0.49%)
GOOGL   136.34 (-0.05%)
AMZN   146.78 (-0.64%)
TSLA   237.31 (+0.52%)
NVDA   477.29 (-1.06%)
NIO   7.16 (-0.42%)
BABA   75.99 (-1.99%)
AMD   121.92 (-0.60%)
T   16.19 (-0.12%)
F   10.32 (-0.19%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.68 (-0.24%)
DIS   94.16 (-1.06%)
AMC   6.65 (-2.21%)
PFE   29.86 (-0.93%)
PYPL   57.10 (+1.26%)
XOM   104.35 (+0.38%)
S&P 500   4,557.28 (+0.15%)
DOW   35,449.75 (+0.33%)
QQQ   389.64 (+0.12%)
AAPL   190.40 (+0.32%)
MSFT   382.10 (+0.92%)
META   336.35 (+0.49%)
GOOGL   136.34 (-0.05%)
AMZN   146.78 (-0.64%)
TSLA   237.31 (+0.52%)
NVDA   477.29 (-1.06%)
NIO   7.16 (-0.42%)
BABA   75.99 (-1.99%)
AMD   121.92 (-0.60%)
T   16.19 (-0.12%)
F   10.32 (-0.19%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.68 (-0.24%)
DIS   94.16 (-1.06%)
AMC   6.65 (-2.21%)
PFE   29.86 (-0.93%)
PYPL   57.10 (+1.26%)
XOM   104.35 (+0.38%)
S&P 500   4,557.28 (+0.15%)
DOW   35,449.75 (+0.33%)
QQQ   389.64 (+0.12%)
AAPL   190.40 (+0.32%)
MSFT   382.10 (+0.92%)
META   336.35 (+0.49%)
GOOGL   136.34 (-0.05%)
AMZN   146.78 (-0.64%)
TSLA   237.31 (+0.52%)
NVDA   477.29 (-1.06%)
NIO   7.16 (-0.42%)
BABA   75.99 (-1.99%)
AMD   121.92 (-0.60%)
T   16.19 (-0.12%)
F   10.32 (-0.19%)
MU   75.02 (-3.21%)
CGC   0.53 (-2.41%)
GE   119.68 (-0.24%)
DIS   94.16 (-1.06%)
AMC   6.65 (-2.21%)
PFE   29.86 (-0.93%)
PYPL   57.10 (+1.26%)
XOM   104.35 (+0.38%)

Open Orphan Share Price, News & Analysis (LON:ORPH)

GBX 10
+0.50 (+5.26%)
(As of 10/25/2022)
Compare
Today's Range
9.50
10.38
50-Day Range
10
10
52-Week Range
8.68
25
Volume
652,639 shs
Average Volume
1.56 million shs
Market Capitalization
£67.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ORPH stock logo

About Open Orphan Stock (LON:ORPH)

Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom.

ORPH Stock Price History

ORPH Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Open Orphan (LON:ORPH) Shares Up 5.3%
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
National Service is Good for Business
See More Headlines
Receive ORPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Open Orphan and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
179
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£34.71 million
Cash Flow
GBX 2.40 per share
Book Value
GBX 3.10 per share

Miscellaneous

Free Float
N/A
Market Cap
£67.09 million
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Cathal Martin Friel (Age 57)
    Exec. Chairman
  • Dr. Yamin Mohammed Khan Ph.D. (Age 52)
    CEO & Director
  • Mr. Leo Toole (Age 49)
    Group CFO & Director
  • John Sheridan
    Chief Operating Officer
  • Mr. Andrew Catchpole
    Chief Scientific Officer
  • Dr. Maurice N. Treacy Ph.D.
    Chief Commercial Officer














ORPH Stock Analysis - Frequently Asked Questions

How have ORPH shares performed in 2023?

Open Orphan's stock was trading at GBX 10 at the beginning of 2023. Since then, ORPH stock has increased by 0.0% and is now trading at GBX 10.
View the best growth stocks for 2023 here
.

How do I buy shares of Open Orphan?

Shares of ORPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ORPH) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -